caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1821256389

Matthew StanizziMD

UrologyNashua, NHI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Matthew Stanizzi's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 23 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
ST JOSEPH HOSPITAL OF NASHUA NH98411
MARY HITCHCOCK MEMORIAL HOSPITAL62144
Daniel Miner
Diagnostic Radiology · Nashua, NH
51169
Benjamin Faitelson
Diagnostic Radiology · Derry, NH
46166
Gary Dunetz
Urology · Nashua, NH
45143
Robert Carbonneau
Diagnostic Radiology · Nashua, NH
4292
Matthew Levine
Diagnostic Radiology · Derry, NH
38107
Philip Grant
Diagnostic Radiology · Derry, NH
3586
Christopher Pyne
Interventional Cardiology · Burlington, MA
34102
GOLDSHEIN, MARK2369
John Bryan
Pathology · Manchester, NH
19113
BERTAGNA, ROBERT1781
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
314
Unique beneficiaries
—
Total services
379
Distinct HCPCS
4
Medicare payment
$22K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 55 Urology providers in NH — bottom quintile (cohort median 1,034).
PRESCRIBING · PART D · 2024
Total Rx claims
864
Beneficiaries
—
Total drug cost
$59K
Distinct drugs
14
Brand share
19.6%
Top prescribed drugs
Tamsulosin Hcl286 claims
Finasteride227 claims
Oxybutynin Chloride74 claims
Terazosin Hcl43 claims
Mirabegron34 claims
QUALITY · MIPS · 2024
Final MIPS score
79.7
Quality
53.5
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.20%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.